Support for immune dysregulation has been provided by meta-analyses (28,29) that have consistently shown that peripheral IL-6 levels are mildly increased in individuals with schizophrenia at the early and established stages as well as in individuals with MDD compared with healthy control participants. This evidence concerns the gene IL6 and major depressive disorder.